tirzepatide glp-1 gip Compounded GLP-1/GIP (3 Month) – Verge Lose up to 20% of your body weight with this simple Frontiers | Clinical perspectives on

Do not re-touch the cleaned area before injecting

Tirzepatide has been a pioneer for both T2D and obesity

It activates two different receptors in the body: GIP (glucose-dependent insulinotropic polypeptide) GLP-1 (glucagon-like peptide-1) By stimulating both, tirzepatide helps: Reduce appetite Increase feelings of fullness Improve insulin sensitivity Lower blood sugar These combined effects help many people eat less and lose more weight over time

Additionally, thin or dehydrated skin has less cushioning to protect blood vessels, making bruising more visible

Clinical studies have shown that patients using tirzepatide often lose a greater percentage of body weight compared to those on placebo or other therapies